Lamotrigin Sandoz

Lamotrigine, the active ingredient in Lamotrigin Sandoz, is an anticonvulsant presented as an oral tablet for oral use. It is employed to control seizures in epilepsy and to stabilize mood in bipolar disorder across adult and pediatric populations, offering a therapeutic option for patients requiring long‑term seizure management or mood stabilization.

GNH USA supplies Lamotrigin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory‑aligned distribution for global healthcare providers.

Lamotrigine is used in the management of seizure disorders and mood stabilization, acting on neuronal excitability.

- Epilepsy (partial seizures): reduces frequency and severity of focal seizures. - Generalized seizures: helps prevent tonic‑clonic and absence seizures. - Bipolar disorder: stabilizes mood and decreases recurrence of depressive episodes.

Lamotrigine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: transient light‑headedness. - Headache: mild to moderate. - Nausea: occasional stomach upset. - Rash: mild skin irritation. - Fatigue: feeling unusually tired. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Aseptic meningitis: inflammation of the meninges without infection. - Severe hypersensitivity reactions: including fever and organ involvement. - Blood dyscrasias: rare cases of agranulocytosis or aplastic anemia.

When prescribing lamotrigine, clinicians should consider several safety measures.

- Initiate therapy at low dose: titrate gradually to reduce rash risk. - Monitor skin reactions: discontinue if severe rash develops. - Assess hepatic function: adjust if significant liver impairment exists. - Review concomitant valproate use: may increase lamotrigine levels. - Evaluate renal function: dose may need adjustment in severe renal failure. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Lamotrigine interacts with several medicines, requiring careful management.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine plasma concentrations. - Carbamazepine: reduces lamotrigine levels, potentially compromising efficacy. - Phenobarbital: accelerates lamotrigine metabolism, lowering exposure.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, necessitating dose review. - Serotonergic agents: combined use may increase risk of serotonin syndrome. - Other antiepileptics (e.g., phenytoin, primidone): may modestly alter lamotrigine concentrations.